MedTrace Logo

Immune Response to Vaccination Against Covid-19, a Follow up Study

NCT04920357 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 3000

Last updated 2021-06-09

No results posted yet for this study

Summary

The study investigates the immune response after vaccination in individuals with and without pre-existing immunity to Coronavirus disease (COVID) -19. The participants are followed and sampled up to 4 years after vaccination. Blood samples are collected at different timepoints to analyze immune response.

The aim is to investigate the level of specific antibodies to Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) yearly, up to 4 years after vaccination.

Conditions

  • Vaccination; Infection
  • Covid19

Interventions

DRUG

Vaccination

Persons that are vaccinated within the national and regional vaccine program are invited to participate in the follow-up study.

Sponsors & Collaborators

  • Region Västerbotten

    collaborator OTHER_GOV

  • Värmland County Council, Sweden

    collaborator OTHER_GOV

  • Örebro Läns Landsting

    collaborator OTHER_GOV

  • Sormland County Council, Sweden

    collaborator OTHER

  • Region Jämtland Härjedalen

    collaborator OTHER

  • Umeå University

    lead OTHER

Principal Investigators

  • Clas Ahlm, Prof · Umeå University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-03-31
Primary Completion
2022-03-31
Completion
2024-12-31
FDA Drug
Yes

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04920357 on ClinicalTrials.gov